Abstract: The Present Invention is a fire starting device for use as kindling manufactured from pine straw, as the primary component, a vegetable oil, natural resins, and an herbal component. The device is hollow, having at least one vertical channel and at least one horizontal channel drilled from the outer wall of the device to the inner vertical channel. The fire starter device is ignited from the top, and it burns to produce a high, intense flame that ignites other flammable materials having a much greater kindling temperature. The height of the flame and the burn duration are controlled by the overall size of the device and the sizes of the channels. The device burns clean with a minimum of smoke and harmful or noxious fumes. Burning the device minimally creates air pollution. It burns completely with a minimum of ash residue.

Abstract: The Present Invention is a fire starting device for use as kindling manufactured from pine straw, as the primary component, a vegetable oil, natural resins, and an herbal component. The composition of the device differs from prior art devices that burn petroleum hydrocarbons. The device is hollow, having at least one vertical channel and at least one horizontal channel drilled from the outer wall of the device to the inner vertical channel. The fire starter device is ignited from the top, and it burns to produce a high, intense flame that ignites other flammable materials having a much greater kindling temperature. The height of the flame and the burn duration are controlled by the overall size of the device and the sizes of the channels. The device burns clean with a minimum of smoke and harmful or noxious fumes. Burning the device minimally creates air pollution. It burns completely with a minimum of ash residue.

Abstract: The Present Invention teaches herbal formulations based on a non-aqueous extract of wrightia tinctoria and an extract of cocos nucifera, which, when applied topically and used as directed in therapeutically effective amounts, have been clinically proven to be safe and effective for people needing treatment for skin conditions such as reducing or regressing dermal tortuosity, reducing spongiform pustules, and reversing and regressing stratum granulosum in keratinization disorders. The formulations can take the form of an ointment, an oil, a soap, or a shampoo.

Abstract: Topical compositions for Safe and Effective regression of Dermal Vessel Tortuosity in Psoriatic Lesions in the form of ointment, cream, oil, soap and shampoo contain non aqueous herbal extract of Wrightia Tinctoria, cocos nucifera, and suitable pharmaceutically/cosmetically accepted excipients for dermal use.

Abstract: Topical compositions for Safe and Effective regression of Stratum Granulosum in keratinization disorders in the form of ointment, cream, oil, soap and shampoo contain non-aqueous herbal extract of Wrightia Tinctoria, cocos nucifera, and suitable pharmaceutically/cosmetically accepted excipients for dermal use.

Abstract: Topical compositions for Safe and Effective regression of Spongiform Pustule in the form of ointment, cream, oil, soap and shampoo contain non aqueous herbal extract of Wrightia Tinctoria, cocos nucifera, and suitable pharmaceutically/cosmetically accepted excipients for dermal use.

Abstract: Topical compositions for Safe and Effective regression of Dermal Vessel Tortuosity in the form of ointment, cream, oil, soap and shampoo contain non aqueous herbal extract of Wrightia Tinctoria, cocos nucifera, and suitable pharmaceutically/cosmetically accepted excipients for dermal use.

Abstract: An electrically assisted transdermal drug delivery system for highly effective electrotransport of an anesthetic and a vasoconstrictor producing clinically acceptable depth and duration of dermal anesthesia at a treatment site. In certain embodiments, the anesthetic comprises lidocaine and the vasoconstrictor comprises epinephrine.

Abstract: The use of an iontophoresis electrode assembly for delivery of a drug formulation is described. The drug formulation includes an anaesthetic and a vasoconstrictor. It is administered to a patient prior to a procedure to produce clinically acceptable depth and duration of dermal anaesthesia at the portion of skin to subject to a painful procedure or to reduce or eliminate pain. The procedure is one selected from the group consisting of venipuncture, IV cannulation, needle aspirations, body piercings, blood donations, electrolysis, tattoo removal, tattoo application, injections, dermabrasion, skin peeling, high velocity particle ablation, pace maker implantation, pace maker replacement, epidural puncture, lumbar puncture, regional nerve blocks, skin harvesting, small skin incisions, skin biopsies, circumcisions or excisions. The iontophoresis electrode assembly may also be used to reduce or temporarily eliminate neuropathic pain.

Abstract: A shelf-stable electrically assisted transdermal drug delivery system for highly effective electrotransport of an anesthetic and a vasoconstrictor producing clinically acceptable dermal anesthesia and sensation is provided. In certain embodiments the anesthetic includes lidocaine and the vasoconstrictor includes epinephrine. Medicament delivery is affected to provide dermal anesthesia with little or no sensation during delivery, as measured by a variety of indicator tests. Methods of producing dermal anesthesia in patients are also provided.

Abstract: Provided are various embodiments of integrated electrode devices, assemblies and systems structured for use in association with electrically assisted delivery devices configured for delivery of a composition, such as a composition comprising gonadotropin-releasing hormone and/or related analogs through a membrane. The integrated electrode devices, assemblies and systems include one or more of a variety of structural, physical, mechanical, electrical and electromechanical enhancements. Methods of administering compositions to patients with integrated electrode devices according to various embodiments described herein are also disclosed.

Abstract: Provided are various embodiments of integrated electrode devices, assemblies and systems structured for use in association with electrically assisted delivery devices configured for delivery of a composition to a membrane. The integrated electrode devices, assemblies and systems include one or more of a variety of structural, physical, mechanical, electrical and electromechanical enhancements.

Abstract: Highly shelf-stable electrically assisted transdermal drug delivery systems for delivering epinephrine, typically with an anesthetic such as lidocaine, are provided along with methods for making the highly shelf-stable epinephrine-containing transdermal delivery device. Highly shelf-stable packaged electrode assemblies for transdermal delivery of epinephrine also are provided.

Abstract: The present invention claims an apparatus for transdermal delivery of medicaments, with novel electrode systems, which avoids burns caused by changes in pH or excessive current applied at the sight of delivery, which is low in cost and easy to manufacture. In the present invention, preferably, the anode of the electrode system is predominantly formed from a low-cost bulk base metal which includes a coating of a precious metal thereon. The cathode of the electrode system is preferably formed from an chemically inert material which is a poor electron condutor and is coated on a good electron conductive material which has poor chemical stability. The electrode system of the present invention is highly efficient, easy to manufacture and cost-effective.

Abstract: In this method, a lower alcohol is oxidized directly (i.e. without reformation) to CO.sub.2 +H.sub.2 O at the anode of a fuel cell, and a reducible gas (e.g. air or O.sub.2) is reduced at the cathode. High, reasonably constant current densities at low over-voltages can be obtained. The electrolyte is preferably an acidic solid polymer electrolyte, and the anode comprises, as the electrocatalyst, a combination of a Group VIII noble metal with gold having significant Au (111) character. The (111) face of gold crystals (preferably crystals in the size range of about 4 to 15 nm) have been found to be specific for oxidation of intermediate alcohol oxidation products (CO, CHO, COH, HCHO, CH.sub.3 CHO, etc.) to CO.sub.2 or CO.sub.2 +H.sub.2 O. Thus, the combination of a Group VIII metal such as Pt with Au (111) avoids "poisoning" of the Pt by these intermediate products.

Abstract: The gas-sensing electrodes prepared according to this invention are specifically designed for cells which operate in a current-limited mode, i.e. at current densities well below 20 mA/cm.sup.2. Such cells are particularly useful to measure or detect a gaseous component of a gaseous environment or stream, provided the gaseous component can be electrochemically oxidized or reduced. In an alkaline, metal-oxygen cell for example, an electrode of this invention can be used as an oxygen cathode. The electrode is prepared by:(a) bringing an exposed face of a self-supporting, electrically-conducting sheet of fibrous or sintered-particle material having a thickness of at least about 30 .mu.m and a flexural strength of at least 2000 kPa into contact with an electrolyte containing ions of a catalytic metal, the electrolyte also being in contact with a counterelectrode,(b) applying a pulsed-D.C.

Abstract: Gas-diffusion electrodes (GDE's) suitable for use with a solid polymer electrolyte (s.p.e.), particularly in s.p.e. fuel cells, which GDE's provide unusually highly efficient use of noble or precious electrocatalytic metals, are obtained by starting with a GDE which is essentially fully fabricated except for electrocatalytic metal treatment and s.p.e. treatment, e.g. a carbon GDE having a gas-permeable hydrophobic face and a particulate carbon-containing catalytic face. This untreated GDE is treated bya. impregnating an s.p.e. solutuion into the catalytic face until the solution penetrates part way into the cross-section of the GDE, especially into the carbon particulate or other support material, but not as far as the hydrophobic, gas permeable face,b. inserting the thus-treated GDE and a counterelectrode into a plating bath containing, for example, M.sup.+, M.sup.++, and/or M.sup.+++ ions, where M is a metal of Group VIII or I-B of the Periodic Table, andc.